Research Highlights

 

 
Health Canada’s COVID-19 response grants funding to three projects at the Lady Davis Institute
Efforts to develop more rapid testing, to determine the potential of existing drugs, and to understand key genetic markers of the immune respond to the coronavirus are underway at the Jewish General Hospit...

  [MORE...]


 
LDI Conferences Postposted
In keeping with the guidelines of Quebec and Canada’s public health authorities, the Lady Davis Institute is conforming with McGill’s Faculty of Medicine decision to cancel or postpone all conf...

  [MORE...]


 
Researchers identify a process responsible for therapeutic resistance in aggressive breast cancer
Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. This holds the promise of opening the doo...

  [MORE...]


 
Cellular origins of pediatric brain tumors identified
Researchers make a breakthrough by identifying that several aggressive pediatric brain tumors are the result of stalled development in embryonic cells.

  [MORE...]


 
Obituary - Dr. Premysl Ponka
It is with deep sorrow that we inform you of the sudden passing of Dr. Premysl Ponka, a distinguished scientist, beloved mentor and colleague, respected teacher, and valued friend.

  [MORE...]


 
Certain Antidepressants Linked to Reduced Risk of Stroke
Selective serotonin reuptake inhibitors, the most commonly prescribed antidepressants, were associated with a reduced risk of ischemic stroke in comparison with those medications that increase serotonin le...

  [MORE...]


 
CCNA at the LADY DAVIS INSTITUTE
ANNOUNCING THE SECOND PHASE OF FUNDING FOR THE CANADIAN CONSORTIUM ON NEURODEGENERATION IN AGING (CCNA)

  [MORE...]


 
More in-depth tumor analysis presents new therapeutic options for patients with advanced cancer
The Segal Cancer Centre is the only Canadian site to participate in an international effort to match patients with personalized medications by delving deeper into tumor biology, offering better options for...

  [MORE...]


 
Jewish General Hospital pioneering new clinical trial to study treating breast cancer without surgery
The Jewish General Hospital is the first hospital in Canada to enroll a patient in an international clinical trial to determine whether some breast cancer patients can completely avoid surgery.

  [MORE...]


 
Obesity, but not age at puberty, associated with increased risk of developing multiple sclerosis
An extensive genetic study conducted at the Lady Davis Institute finds that obesity, rather than early puberty, may be influencing increasing rates of multiple sclerosis.

  [MORE...]

12345
Support research at the Lady Davis Institute - Jewish General Hospital